Fertility and Sterility

• 

  Publication Venue For

  • Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome..  119:847-857. 2023
  • Cessation of chronic delta-9-tetrahydrocannabinol use partially reverses impacts on male fertility and the sperm epigenome in rhesus macaques. 2023
  • Markers of ovarian reserve as predictors of future fertility..  119:99-106. 2023
  • The risky business of advanced paternal age: neurodevelopmental and psychosocial implications for children of older fathers..  118:1013-1021. 2022
  • Effects of risk factors for ovarian cancer in women with and without endometriosis..  118:960-969. 2022
  • Fibroids in pregnancy: a growing or shrinking issue?.  118:666-667. 2022
  • Sibling rivalry? Higher birthweight after frozen embryo transfer compared with fresh sibling embryo transfers..  118:335-336. 2022
  • Route of myomectomy and fertility: a prospective cohort study..  117:1083-1093. 2022
  • Do not increase the burden for poor responders..  117:756-757. 2022
  • Defining recurrent implantation failure: a profusion of confusion or simply an illusion?.  116:1432-1435. 2021
  • The Appraisal of Body Content (ABC) trial: Increased male or female adiposity does not significantly impact in vitro fertilization laboratory or clinical outcomes..  116:444-452. 2021
  • Vitamin D and uterine leiomyomata: Is it time to let the sunshine in?.  115:340-341. 2021
  • Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion..  114:1158-1164. 2020
  • Testing and interpreting measures of ovarian reserve: a committee opinion..  114:1151-1157. 2020
  • Cycle scheduling with oral contraceptives: Are we compromising rates for convenience?.  114:743-744. 2020
  • Cystic fibrosis carrier screening using next generation sequencing: A cautionary tale..  114:495-496. 2020
  • Bioinformatic jujutsu to defeat an endometrial transcriptomic foe..  113:1163-1164. 2020
  • Academic pursuits in board-certified reproductive endocrinologists..  113:653-660.e1. 2020
  • Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids..  113:618-626. 2020
  • Evidence-based treatments for couples with unexplained infertility: a guideline..  113:305-322. 2020
  • Interpretation of clinical trial results: a committee opinion..  113:295-304. 2020
  • Clinical pregnancy and live birth increase significantly with every additional blastocyst up to five and decline after that: an analysis of 16,666 first fresh single-blastocyst transfers from the Society for Assisted Reproductive Technology registry..  112:866-873.e1. 2019
  • Reprint of: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome..  112:e174-e177. 2019
  • Reprint of: Histological dating of timed endometrial biopsy tissue is not related to fertility status..  112:e116-e124. 2019
  • Clinical pregnancy (CP) and live birth (LB) increase significantly with each additional fertilized oocyte up to nine, and CP and LB decline after that: an analysis of 15,803 first fresh in vitro fertilization cycles from the Society for Assisted Reproductive Technology registry..  112:520-526.e1. 2019
  • Postoperative adhesions in gynecologic surgery: a committee opinion..  112:458-463. 2019
  • Nurses are an asset to an in vitro fertilization program, and more so if they are continually educated..  112:232. 2019
  • Should we stop offering endometrial scratching prior to in vitro fertilization?.  111:1094-1101. 2019
  • Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion..  111:659-663. 2019
  • What exactly is endometrial receptivity?.  111:611-617. 2019
  • Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry..  110:880-887. 2018
  • Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage..  110:896-904. 2018
  • Quest for a less invasive approach to preimplantation genetic testing remains ongoing..  110:845-846. 2018
  • Celiac disease is not more prevalent in patients undergoing in vitro fertilization and does not affect reproductive outcomes with or without treatment: a large prospective cohort study..  110:437-442. 2018
  • Infertility patients in general and those with celiac disease may be able to breathe a sigh of relief..  110:405. 2018
  • Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis..  109:1072-1078. 2018
  • Androgens and endometrium: new lessons from the corpus luteum via the adrenal cortex?.  109:623-624. 2018
  • What do we know about the relationships between preconception parental health, infertility, and pregnancy outcomes?.  109:248-249. 2018
  • An unanswered call: where is multilevel modeling in male infertility research involving semen parameters? 2018
  • Evaluation of endometrial function: a Heraclean or Sisyphean task?.  108:604-605. 2017
  • High relative deoxyribonucleic acid content of trophectoderm biopsy adversely affects pregnancy outcomes..  107:731-736.e1. 2017
  • Distribution of the FMR1 gene in females by race/ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study)..  107:205-211.e1. 2017
  • Immune-inflammation gene signatures in endometriosis patients..  106:1420-1431.e7. 2016
  • Do donor oocyte cycles comply with ASRM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry..  106:603-607. 2016
  • Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies..  106:660-665. 2016
  • How compliant are in vitro fertilization member clinics in following embryo transfer guidelines? An analysis of 59,689 fresh first in vitro fertilization autologous cycles from 2011 to 2012..  106:645-652.e1. 2016
  • Immunologic challenges of human reproduction: an evolving story..  106:499-510. 2016
  • Introduction: Reproductive immunology: checkered past and bright future..  106:497-498. 2016
  • Practice patterns, satisfaction, and demographics of reproductive endocrinologists: results of the 2014 Society for Reproductive Endocrinology and Infertility Workforce Survey..  105:1281-1286. 2016
  • Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients..  105:968-977.e5. 2016
  • Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry..  105:663-669. 2016
  • Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry..  105:364-368. 2016
  • Evidence of a genetic link between endometriosis and ovarian cancer..  105:35-43.e1-10. 2016
  • Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry..  104:873-878. 2015
  • Third-party reproduction in the Internet Age: the new, patient-centered landscape..  104:525-530. 2015
  • Analysis of semen parameters in male referrals: impact of reference limits, stratification by fertility categories, predictors of change, and comparison of normal semen parameters in subfertile couples..  103:59-65.e5. 2015
  • Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology..  102:399-404. 2014
  • Peri-implantation intercourse lowers fecundability..  102:178-182. 2014
  • Prospective assessment of midsecretory endometrial leukemia inhibitor factor expression versus ανβ3 testing in women with unexplained infertility..  101:1724-1731. 2014
  • Using Society for Assisted Reproductive Technology data to track pregnancy outcomes in older recipients: is it justifiable?.  101:e43. 2014
  • Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology..  101:1331-1336. 2014
  • Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles..  101:967-973. 2014
  • Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy..  99:768-776.e1. 2013
  • Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome..  96:1043-1047. 2011
  • Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial..  96:704-710. 2011
  • Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited..  95:2449-2455. 2011
  • Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis..  95:1786.e13-1786.e16. 2011
  • Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis..  95:906-14.e1-4. 2011
  • Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort..  95:40-45. 2011
  • Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase..  95:247-253. 2011
  • Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas..  94:1864-1868. 2010
  • Body mass index and intercourse compliance..  94:1447-1450. 2010
  • Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial..  94:1444-1446. 2010
  • Racial diversity in uterine leiomyoma clinical studies..  94:1500-1503. 2010
  • Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey..  93:499-509. 2010
  • Effects of variations in serum estradiol concentrations on secretory endometrial development and function in experimentally induced cycles in normal women..  92:2058-2061. 2009
  • Fewer medications for in vitro fertilization can be better: thinking outside the box..  92:1187-1189. 2009
  • Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism..  92:979-990. 2009
  • Heterotopic cervical pregnancy treated with transvaginal ultrasound-guided aspiration resulting in cervical site varices within the myometrium..  91:934.e19-934.e22. 2009
  • Keeping clinicians in clinical research: the Clinical Research/Reproductive Scientist Training Program..  91:664-666. 2009
  • A case of female epispadias..  90:2017.e1-2017.e3. 2008
  • Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate..  90:1161-1168. 2008
  • Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial..  90:1283-1286. 2008
  • Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders..  90:673-677. 2008
  • Luteal supplementation in in vitro fertilization: more questions than answers..  89:749-758. 2008
  • Simple vaginal mold for use in the postoperative care of patients with a transverse vaginal septum..  87:1225-1226. 2007
  • The FMR1 premutation and reproduction..  87:456-465. 2007
  • Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome..  87:442-444. 2007
  • Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome..  86:1292-1295. 2006
  • Ectopic pregnancy in a preexisting hydrosalpinx during a spontaneous pregnancy..  86:1001.e11-1001.e13. 2006
  • The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects..  86:914-933. 2006
  • Optimal stimulation protocols for in vitro fertilization..  86:267-273. 2006
  • Factors that affect infertility patients' decisions about disposition of frozen embryos..  85:1623-1630. 2006
  • Acupuncture as adjunctive therapy in assisted reproduction: remaining uncertainties..  85:1362-1363. 2006
  • Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique outcomes..  84:900-909. 2005
  • Redefining the relationship between sperm deoxyribonucleic acid fragmentation as measured by the sperm chromatin structure assay and outcomes of assisted reproductive techniques..  84:356-364. 2005
  • Rectus sheath hematoma after transvaginal follicle aspiration: a rare complication of in vitro fertilization..  84:217. 2005
  • Endometrial dating--still room for controversy..  83:1889-1890. 2005
  • T-helper 2 and 3 type immunity to trophoblast in successful in vitro fertilization-embryo transfer..  83:1659-1664. 2005
  • Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. 2020
  • Perinatal outcomes following intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilization (IVF) 2016
  • Serum peak estradiol and neonatal birth weight following in vitro fertilization 2016